Suscribirse

Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets - 12/12/21

Doi : 10.1016/j.biopha.2021.112420 
Masoumeh Farahani a, 1, Zahra Niknam a, 1, Leila Mohammadi Amirabad b, Nasrin Amiri-Dashatan a, c, Mehdi Koushki d, Mohadeseh Nemati e, Fahima Danesh Pouya e, Mostafa Rezaei-Tavirani f, , Yousef Rasmi e, g, , Lobat Tayebi b
a Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
b Marquette University School of Dentistry, Milwaukee, WI 53233, USA 
c Zanjan Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran 
d Department of Clinical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran 
e Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran 
f Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
g Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran 

Correspondence to: Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran 19716-53313, Iran.Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical SciencesTehran19716-53313Iran⁎⁎Corresponding author at: Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran.Cellular and Molecular Research Center, Urmia University of Medical SciencesUrmiaIran.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Deciphering the molecular downstream consequences of severe acute respiratory syndrome coronavirus (SARS-CoV)− 2 infection is important for a greater understanding of the disease and treatment planning. Furthermore, greater understanding of the underlying mechanisms of diagnostic and therapeutic strategies can help in the development of vaccines and drugs against COVID-19. At present, the molecular mechanisms of SARS-CoV-2 in the host cells are not sufficiently comprehended. Some of the mechanisms are proposed considering the existing similarities between SARS-CoV-2 and the other members of the β-CoVs, and others are explained based on studies advanced in the structure and function of SARS-CoV-2. In this review, we endeavored to map the possible mechanisms of the host response following SARS-CoV-2 infection and surveyed current research conducted by in vitro, in vivo and human observations, as well as existing suggestions. We addressed the specific signaling events that can cause cytokine storm and demonstrated three forms of cell death signaling following virus infection, including apoptosis, pyroptosis, and necroptosis. Given the elicited signaling pathways, we introduced possible pathway-based therapeutic targets; ADAM17 was especially highlighted as one of the most important elements of several signaling pathways involved in the immunopathogenesis of COVID-19. We also provided the possible drug candidates against these targets. Moreover, the cytokine-cytokine receptor interaction pathway was found as one of the important cross-talk pathways through a pathway-pathway interaction analysis for SARS-CoV-2 infection.

El texto completo de este artículo está disponible en PDF.

Graphical Abstract




ga1

El texto completo de este artículo está disponible en PDF.

Highlights

Potential molecular pathways involved in SARS-CoV-2 infection were investigated.
Pathway-based therapeutic targets were identified.
The importance of ADAM17 in several dysregulated molecular pathways was highlighted.
The predominant role of cytokine-cytokine receptor interaction pathway in cross-talk between pathways was indicated.

El texto completo de este artículo está disponible en PDF.

Abbreviations : COVID-19, SARS-CoV-2, ACE2, RAS, TNF-α, JNK, ERK, ACE, AT1R, PARP-1, PARG, TRPM2, TMPRSS2, ADAM17, ARDS, PAMP, PRRs, TLRs, NF-κB, JAK/STAT, mTOR, MAPKs, HIF-1, NLRP3

Keywords : COVID-19, SARS-CoV-2, Molecular pathway, Drug targets


Esquema


© 2021  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 145

Artículo 112420- janvier 2022 Regresar al número
Artículo precedente Artículo precedente
  • The molecular mechanisms of ferroptosis and its role in cardiovascular disease
  • Yang Zhang, Laiyun Xin, Mi Xiang, Chang Shang, Yuling Wang, Yan Wang, Xiangning Cui, Yingdong Lu
| Artículo siguiente Artículo siguiente
  • mTOR pathway: A potential therapeutic target for spinal cord injury
  • Yi Ding, Qin Chen

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.